In today’s briefing:
- Ohayo Japan | Wall Street Slumps as S&P 500 Enters Correction
- Japan Morning Connection: Tariff War Escalation Zaps Yesterdays Growth Rebound
- How India Is Powering Up Its Summer Energy Demand?
- How to Think About the Ongoing Correction? Is It a 10% Correction or a Big Crash?
- Charted Insights: A Deeper Look into Indian Market’s Historical Corrections
- #118 India Insight: Promoter Backs IndusInd, Adani’s Vizhinjam Port Gets Nod, Cotton Imports Surge
- New Mineral Tax in Tamil Nadu: Impact on Cement Producers
- ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025

Ohayo Japan | Wall Street Slumps as S&P 500 Enters Correction
- S&P 500 fell 1.4% into correction, Nasdaq dropped 2%, and Dow lost 550 points amid trade war fears, government shutdown risks, and weak inflation data.
- Nikkei dipped 0.1% as BOJ rate hike concerns strengthened the yen; futures point to another weak open
- Corporate Moves: SoftBank’s ¥1tn AI data center, Canon’s ¥100bn buyback, Toyota’s EV push, and ACT prepares “divestiture package” for Seven & i’s takeover.
Japan Morning Connection: Tariff War Escalation Zaps Yesterdays Growth Rebound
- Yesterday’s tech gains failing to hold setting a muted tone to start for JP peers.
- Softbank’s $7bn data center buildout with Open AI may need 100,000 GPU’s.
- Kose upgrade + Ulta Beauty better than expected after market numbers points to upside off lows.
How India Is Powering Up Its Summer Energy Demand?
- India faces record electricity demand due to rising temperatures and industrial growth, expecting to reach 270 GW this summer, which raises concerns about grid readiness.
- To meet this surge, India is expanding its power generation, relying heavily on coal for energy security, while gradually incorporating renewables, hydro, and nuclear energy.
- This approach creates a paradox, as burning more fossil fuels to cope with heatwaves worsens the climate crisis, underscoring the urgent need for clean energy infrastructure and grid modernization.
How to Think About the Ongoing Correction? Is It a 10% Correction or a Big Crash?
- This article focuses on the S&P. Composition, valuations, technical indicators to watch.
- Overall, it looks bad with a strong downward momentum. This market does start to expect a recession. We’re at the juncture.
- This is part 1. Part 2 on Monday: specific stocks
Charted Insights: A Deeper Look into Indian Market’s Historical Corrections
- Indian equities have seen a broad-based correction, with the Nifty-50 down ~16% from its peak, driven by weak earnings, heavy FII outflows, and global uncertainty.
- However, multiple indicators—from easing valuations and supportive policies to an expected earnings rebound—suggest the correction may be nearing its end.
- This blog explores past correction trends and key signals pointing to a potential market reversal in FY26.
#118 India Insight: Promoter Backs IndusInd, Adani’s Vizhinjam Port Gets Nod, Cotton Imports Surge
- Ashok Hinduja assures support for Indusind Bank (IIB IN) after a steep stock fall from derivative losses, citing strong financials.
- Adani’s Vizhinjam Port secures green clearance for expansion, positioning India to reclaim transshipment volumes lost to foreign ports.
- India’s cotton imports may double as domestic output lags demand, forcing a shift in trade dynamics and impacting global prices.
New Mineral Tax in Tamil Nadu: Impact on Cement Producers
- Tamil Nadu has imposed a INR 160/tonne tax on limestone, using a recent Supreme Court ruling that empowers states to levy mineral-bearing land taxes.
- Limestone is a major cost component for cement. This tax could shrink EBITDA by up to 9% for exposed players and trigger similar levies in other states.
- Cement sector cost structures now face structural regulatory risk. Monitor pricing discipline closely- margins hinge on the industry’s ability to pass on this burden.
ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025
- Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market.
- Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge.
- Diabetes is a chronic metabolic disorder characterized by high blood sugar levels.